Envoy Medical (COCH) Income towards Parent Company (2021 - 2026)

Envoy Medical has reported Income towards Parent Company for 6 years, with the latest figure at -$6.2 million in Q1 2026.

• Quarterly Income towards Parent Company fell 11.09% year-over-year to -$6.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$24.5 million (up 98.75% YoY) and the FY2025 annual result came in at -$23.9 million, up 1.45% from the prior year.
• Income towards Parent Company rose to -$6.2 million in Q1 2026 per COCH's latest filing, from -$6.4 million in the prior quarter.
• Over five years, Income towards Parent Company peaked at $12.5 million in Q1 2022 and troughed at -$1.9 billion in Q3 2024.
• A 5-year average of -$116.4 million and a median of -$5.0 million in 2024 frame the typical range for Income towards Parent Company.
• The sharpest annual moves came in 2022 and 2024: Income towards Parent Company soared 1400.18% in 2022, then slumped 45325.56% in 2024.
• Over 5 years, Income towards Parent Company stood at -$2.0 million in 2022, then slumped by 150.9% to -$5.0 million in 2023, then increased by 2.12% to -$4.9 million in 2024, then dropped by 29.43% to -$6.4 million in 2025, then gained by 2.54% to -$6.2 million in 2026.
• According to Business Quant data, Income towards Parent Company over the past three periods registered -$6.2 million, -$6.4 million, and -$6.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.